If you need more lookups,
subscriptions start at $34 USD/month.
Heidi Wang Location
New York, NY, US
Heidi Wang Work
Chairwoman @ (March 2025 - Present)
Chief Executive Officer @ (June 2023 - Present)
Mentor @ Taiwan Innovative Drug Industry (August 2022 - Present)
Bristol-Myers Squibb @
Mentor @ Taiwan Innovative Drug Industry (July 2022 - Present)
Therapeutic Area Head Oncology, Vice President, Global Regulatory Strategy and Policy @ (November 2019 - May 2023)
Head, Global Regulatory Sciences China, including Hong Kong @ (August 2016 - February 2020)
International Strategy Lead (Group Director) @ (October 2015 - August 2016)
International Strategy Lead (Director) @ (April 2013 - September 2015)
Global Labeling Strategist (Associate Director) @ (April 2007 - September 2010)
Senior Scientific Writer @ (May 2005 - April 2007)
Senior Research Investigator @ (January 1994 - May 2005)
Heidi Wang Education
Cold Spring Harbor Laboratory
(Virology)
1990-1993
Notre Dame
Doctor of Philosophy (Molecular Biology, Virology)
1983-1990
Fu - Jen university
Bachelor of Science (Biology)
Heidi Wang Skills
FDA
Therapeutic Areas
Drug Development
Medical Writing
Virology
Oncology
Clinical Development
Regulations
Drug Discovery
IND
Neuroscience
GCP
Clinical Study Design
Cross-functional Team Leadership
Regulatory Submissions
Clinical Trials
CRO
Infectious Diseases
Pharmaceutical Industry
Regulatory Affairs
Immunology
Biopharmaceuticals
Mentoring
Professional Mentoring
Staff Mentoring
Team Mentoring
U.S. Food and Drug Administration (FDA)
Heidi Wang Summary
Heidi Wang, based in New York, NY, US, is currently a Chairwoman at OBIGEN PHARMA. Heidi Wang brings experience from previous roles at OBI Pharma, Inc, Taiwan Innovative Drug Industry and Bristol-Myers Squibb. Heidi Wang holds a 1990 - 1993 Cold Spring Harbor Laboratory. With a robust skill set that includes FDA, Therapeutic Areas, Drug Development, Medical Writing, Virology and more. Heidi Wang has 4 emails on RocketReach.
Looking for a different Heidi Wang?
Find contact details for 700 million professionals.